Bhatia; Mickie

Patent Applications and Registrations

Patent applications and USPTO patent grants for Bhatia; Mickie.The latest application filed is for "prognosis and treatment of relapsing leukemia".

Company Profile

2.13.25

Bhatia; Mickie - Ancaster CA
BHATIA; Mickie - London CA
Bhatia; Mickie - Hamilton CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Prognosis And Treatment Of Relapsing Leukemia App 20200080157 - Bhatia; Mickie ; et al.	2020-03-12
Methods For Regulation Of Stem Cells App 20200009188 - MOON; Randall T. ; et al.	2020-01-09
Reconstituting Hematopoietic Cell Function Using Human Embryonic Stem Cells App 20180353606 - Bhatia; Mickie	2018-12-13
Generating Induced Neural Progenitor Cells From Blood App 20180148687 - Bhatia; Mickie ; et al.	2018-05-31
Combination Therapy For The Treatment Of Cancer App 20170071971 - Bhatia; Mickie ; et al.	2017-03-16
Methods for identifying and validating selective anti-cancer stem cell agents Grant 9,566,282 - Bhatia , et al. February 14, 2	2017-02-14
Combination therapy for the treatment of cancer Grant 9,486,471 - Bhatia , et al. November 8, 2	2016-11-08
Transformed Human Pluripotent Stem Cells And Associated Methods App 20160264935 - Bhatia; Mickie ; et al.	2016-09-15
Transformed human pluripotent stem cells and associated methods Grant 9,365,821 - Bhatia , et al. June 14, 2	2016-06-14
Generating induced pluripotent stem cells and progenitor cells from fibroblasts Grant 9,340,772 - Bhatia , et al. May 17, 2	2016-05-17
Compounds And Methods For Selectively Targeting Cancer Stem Cells App 20150224169 - Bhatia; Mickie ; et al.	2015-08-13
Transformed Human Pluripotent Stem Cells And Associated Methods App 20150038371 - Bhatia; Mickie ; et al.	2015-02-05
Combination Therapy For The Treatment Of Cancer App 20150038450 - Bhatia; Mickie ; et al.	2015-02-05
Combination therapy for the treatment of cancer Grant 8,809,299 - Bhatia , et al. August 19, 2	2014-08-19
Treatment of Cancer WIth Dopamine Receptor Antagonists App 20130331381 - Bhatia; Mickie ; et al.	2013-12-12
Combination Therapy For The Treatment Of Cancer App 20130261074 - Bhatia; Mickie ; et al.	2013-10-03
Methods For Regulation Of Stem Cells App 20130209430 - MOON; Randall T. ; et al.	2013-08-15
Treatment of Cancer with Dopamine Receptor Antagonists App 20130065887 - Bhatia; Mickie ; et al.	2013-03-14
Methods for regulation of stem cells Grant 8,372,397 - Moon , et al. February 12, 2	2013-02-12
Transformed Human Pluripotent Stem Cells And Associated Methods App 20120252697 - Bhatia; Mickie ; et al.	2012-10-04
Generating Induced Pluripotent Stem Cells And Progenitor Cells From Fibroblasts App 20120214236 - Bhatia; Mickie ; et al.	2012-08-23
Methods For Regulation Of Stem Cells App 20110091448 - MOON; Randall T. ; et al.	2011-04-21
Methods for regulation of stem cells Grant 7,850,960 - Moon , et al. December 14, 2	2010-12-14
Using undifferentiated embryonic stem cells to control the immune system Grant 7,799,324 - Bhatia , et al. September 21, 2	2010-09-21
Regeneration initiating cells Grant 7,527,968 - Bhatia May 5, 2	2009-05-05
Methods for regulation of stem cells App 20060147435 - Moon; Randall T. ; et al.	2006-07-06
Regeneration initiating cells App 20060140913 - Bhatia; Mickie	2006-06-29
Using undifferentiated embryonic stem cells to control the immune system App 20050282272 - Bhatia, Mickie ; et al.	2005-12-22
Reconstituting hematopoietic cell function using human embryonic stem cells App 20040224403 - Bhatia, Mickie	2004-11-11
Method for making hematopoietic cells App 20040110286 - Bhatia, Mickie	2004-06-10
Hematopoietic cells from human embryonic stem cells App 20030153082 - Bhatia, Mickie	2003-08-14

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.